These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 35675498

  • 1. Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study.
    Vellanki P, Cardona S, Galindo RJ, Urrutia MA, Pasquel FJ, Davis GM, Fayfman M, Migdal A, Peng L, Umpierrez GE.
    Diabetes Care; 2022 Oct 01; 45(10):2217-2223. PubMed ID: 35675498
    [Abstract] [Full Text] [Related]

  • 2. Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial.
    Umpierrez GE, Smiley D, Hermayer K, Khan A, Olson DE, Newton C, Jacobs S, Rizzo M, Peng L, Reyes D, Pinzon I, Fereira ME, Hunt V, Gore A, Toyoshima MT, Fonseca VA.
    Diabetes Care; 2013 Aug 01; 36(8):2169-74. PubMed ID: 23435159
    [Abstract] [Full Text] [Related]

  • 3. Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes.
    Smiley D, Umpierrez GE, Hermayer K, Newton C, Jacobs S, Olson DE, Khan A, Rizzo M, Peng L, Reyes D, Cardona S, Fonseca V.
    J Diabetes Complications; 2013 Aug 01; 27(6):637-41. PubMed ID: 23911535
    [Abstract] [Full Text] [Related]

  • 4. Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial.
    Vellanki P, Rasouli N, Baldwin D, Alexanian S, Anzola I, Urrutia M, Cardona S, Peng L, Pasquel FJ, Umpierrez GE, Linagliptin Inpatient Research Group.
    Diabetes Obes Metab; 2019 Apr 01; 21(4):837-843. PubMed ID: 30456796
    [Abstract] [Full Text] [Related]

  • 5. BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA.
    Bueno E, Benitez A, Rufinelli JV, Figueredo R, Alsina S, Ojeda A, Samudio S, Cáceres M, Argüello R, Romero F, Echagüe G, Pasquel F, Umpierrez GE.
    Endocr Pract; 2015 Jul 01; 21(7):807-13. PubMed ID: 26121460
    [Abstract] [Full Text] [Related]

  • 6. Reliability of Inpatient CGM: Comparison to Standard of Care.
    Price C, Ditton G, Russell GB, Aloi J.
    J Diabetes Sci Technol; 2023 Mar 01; 17(2):329-335. PubMed ID: 34911384
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study.
    Umpierrez GE, Gianchandani R, Smiley D, Jacobs S, Wesorick DH, Newton C, Farrokhi F, Peng L, Reyes D, Lathkar-Pradhan S, Pasquel F.
    Diabetes Care; 2013 Nov 01; 36(11):3430-5. PubMed ID: 23877988
    [Abstract] [Full Text] [Related]

  • 8. Randomized controlled trial of insulin supplementation for correction of bedtime hyperglycemia in hospitalized patients with type 2 diabetes.
    Vellanki P, Bean R, Oyedokun FA, Pasquel FJ, Smiley D, Farrokhi F, Newton C, Peng L, Umpierrez GE.
    Diabetes Care; 2015 Apr 01; 38(4):568-74. PubMed ID: 25665812
    [Abstract] [Full Text] [Related]

  • 9. A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial.
    Umpierrez GE, Cardona S, Chachkhiani D, Fayfman M, Saiyed S, Wang H, Vellanki P, Haw JS, Olson DE, Pasquel FJ, Johnson TM.
    J Am Med Dir Assoc; 2018 May 01; 19(5):399-404.e3. PubMed ID: 29289540
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes.
    Bellido V, Suarez L, Rodriguez MG, Sanchez C, Dieguez M, Riestra M, Casal F, Delgado E, Menendez E, Umpierrez GE.
    Diabetes Care; 2015 Dec 01; 38(12):2211-6. PubMed ID: 26459273
    [Abstract] [Full Text] [Related]

  • 11. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
    Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, Puig A, Mejia R.
    Diabetes Care; 2007 Sep 01; 30(9):2181-6. PubMed ID: 17513708
    [Abstract] [Full Text] [Related]

  • 12. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery).
    Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, Umpierrez D, Newton C, Olson D, Rizzo M.
    Diabetes Care; 2011 Feb 01; 34(2):256-61. PubMed ID: 21228246
    [Abstract] [Full Text] [Related]

  • 13. A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial.
    Pasquel FJ, Lansang MC, Khowaja A, Urrutia MA, Cardona S, Albury B, Galindo RJ, Fayfman M, Davis G, Migdal A, Vellanki P, Peng L, Umpierrez GE.
    Diabetes Care; 2020 Jun 01; 43(6):1242-1248. PubMed ID: 32273271
    [Abstract] [Full Text] [Related]

  • 14. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
    Hollander P, Cooper J, Bregnhøj J, Pedersen CB.
    Clin Ther; 2008 Nov 01; 30(11):1976-87. PubMed ID: 19108786
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: A systematic review and meta-analysis.
    Christensen MB, Gotfredsen A, Nørgaard K.
    Diabetes Metab Res Rev; 2017 Jul 01; 33(5):. PubMed ID: 28067472
    [Abstract] [Full Text] [Related]

  • 16. COMPARISON OF EFFICACY AND SAFETY OF GLARGINE AND DETEMIR INSULIN IN THE MANAGEMENT OF INPATIENT HYPERGLYCEMIA AND DIABETES.
    Galindo RJ, Davis GM, Fayfman M, Reyes-Umpierrez D, Alfa D, Peng L, Tamler R, Pasquel FJ, Umpierrez GE.
    Endocr Pract; 2017 Sep 01; 23(9):1059-1066. PubMed ID: 28683239
    [Abstract] [Full Text] [Related]

  • 17. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
    Heller S, Koenen C, Bode B.
    Clin Ther; 2009 Oct 01; 31(10):2086-97. PubMed ID: 19922879
    [Abstract] [Full Text] [Related]

  • 18. Addressing hyperglycemia from hospital admission to discharge.
    Moghissi ES.
    Curr Med Res Opin; 2010 Mar 01; 26(3):589-98. PubMed ID: 20078323
    [Abstract] [Full Text] [Related]

  • 19. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.
    Clin Ther; 2007 Nov 01; 29(11):2349-64. PubMed ID: 18158076
    [Abstract] [Full Text] [Related]

  • 20. Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy.
    Gosmanov AR, Goorha S, Stelts S, Peng L, Umpierrez GE.
    Endocr Pract; 2013 Nov 01; 19(2):231-5. PubMed ID: 23337144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.